THOMPSON DAVIS & CO., INC. - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 3.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$13,000
-74.0%
1,534
-70.1%
0.03%
-76.5%
Q2 2018$50,000
+11.1%
5,1250.0%0.12%0.0%
Q1 2018$45,000
-29.7%
5,1250.0%0.12%
-21.7%
Q4 2017$64,0005,1250.15%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 25,445$19,0000.05%
ETF MANAGERS GROUP, LLC 2,258,970$1,654,0000.05%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 116,780$85,0000.02%
GSA CAPITAL PARTNERS LLP 131,036$96,0000.01%
Bernardo Wealth Planning LLC 30,469$20,0000.01%
PCG Wealth Advisors, LLC 15,200$12,0000.00%
Penserra Capital Management LLC 212,298$155,0000.00%
ZEKE CAPITAL ADVISORS, LLC 49,700$36,0000.00%
King Wealth Management Group 16,000$12,0000.00%
Vident Investment Advisory, LLC 105,398$77,0000.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders